Status:
UNKNOWN
Supplementation With Vitamin D Improves Leptin Resistance
Lead Sponsor:
Mexican National Institute of Public Health
Conditions:
Overweight
Obesity
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
Participants will be randomly assigned in one of two groups. Group A: oral supplementation with 4,000 IU of vitamin D (cholecalciferol). Group B: oral supplementation with 400 IU of vitamin D (choleca...
Detailed Description
Study subjects will get dietary advice and physical activity counseling. At the end of the study, participants with suboptimal vitamin D levels (\<80 nmol/L 25-OH-D) will receive treatment to normaliz...
Eligibility Criteria
Inclusion
- BMI: 25-29.9
- Serum vitamin D levels: 20-80 nmol/L (25-OH-D)
Exclusion
- Liver disease
- Kidney disease
- Diabetes mellitus
- Malignity
- Any kind of hormonal disorder
- Medication that modify hunger/satiety answer and those medications that alter -the glucose/insulin metabolism
- Subjects with diet treatment to lose weight
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00907270
Start Date
September 1 2009
End Date
May 1 2010
Last Update
May 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Social Insurance
Cuernavaca, Morelos, Mexico, 62450